Among brain tumors, besides the already established entities such as pleomophic xanthoastrocytoma and ganglioglioma, especially epithelioid glioblastomas, astrocytic tumors occurring before the age of 30 years as well as rhabdoid meningiomas should undergo routine BRAF V600E mutation analysis. This evidence concerns the gene BRAF and ganglioglioma.